Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients

J Am Acad Dermatol. 2020 Nov;83(5):1478-1479. doi: 10.1016/j.jaad.2020.03.034. Epub 2020 Mar 22.

Authors

Fathima Ferial Ismail¹, Nekma Meah², Lara Trindade de Carvalho², Bevin Bhoyrul², Dmitri Wall², Rodney Sinclair³

Affiliations

¹ Sinclair Dermatology, East Melbourne, Victoria, Australia. Electronic address: f.ferial.ismail@gmail.com.
² Sinclair Dermatology, East Melbourne, Victoria, Australia.
³ Sinclair Dermatology, East Melbourne, Victoria, Australia; University of Melbourne, Melbourne, Victoria, Australia; Department of Dermatology, Epworth Healthcare, Melbourne, Victoria, Australia.

PMID: 32213304
DOI: 10.1016/j.jaad.2020.03.034

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Alopecia / drug therapy*
Androgen Antagonists / administration & dosage*
Androgen Antagonists / adverse effects
Anilides / administration & dosage*
Anilides / adverse effects
Female
Humans
Middle Aged
Nitriles / administration & dosage*
Nitriles / adverse effects
Retrospective Studies
Tosyl Compounds / administration & dosage*
Tosyl Compounds / adverse effects
Young Adult

Substances

Androgen Antagonists
Anilides
Nitriles
Tosyl Compounds
bicalutamide